University of California
Foundational research into micro-sensor arrays, high-density EMG decoding algorithms, and peripheral nerve signal processing techniques.
Company Profile
A Neuro-AI Innovation Leader Headquartered in Minnesota
Fasikl Inc. is a pioneering medical technology enterprise dedicated to advancing bioelectronic medicine and digital therapeutics. Grounded in more than two decades of intensive research and development across world-class academic research centers — including the University of California (2004–2010), National University of Singapore (2010–2015), and University of Minnesota (2015–2020) — Fasikl was established commercially in 2019 to operationalize breakthrough neural engineering into regulatory-approved medical devices.
By merging proprietary neuro-microchip architectures, multi-channel biosignal decoding, and cloud-based deep learning, Fasikl has created an entirely new category: AI Therapeutics. Instead of static electrical stimulation, our platforms interact bidirectional with the nervous system to deliver targeted, real-time therapy tailored dynamically to each patient.
Core Mission & Purpose
Our core imperative is to engineer noninvasive, drug-free therapeutic devices that restore motor control, enhance independence, and improve quality of life for millions of individuals living with movement disorders globally.
Academic & Industrial Lineage
Over 20 Years of Scientific Rigor
Fasikl's clinical innovations stem from long-term institutional research programs across premier global neural engineering facilities.
National University of Singapore
Development of custom bioelectronic neuro-microchips and low-latency digital signal processing architectures for real-time motor intent classification.
Univ. of Minnesota & Fasikl Inc.
Pioneering closed-loop peripheral nerve stimulation models, cloud-integrated AI calibration systems, and executing multi-center clinical trials culminating in FDA regulatory clearance.
Technical Competence
Proprietary Engineering Core
Fasikl's medical devices combine hardware, software, and clinical AI into a seamless therapeutic execution loop.
Patented Neuro-Microchips
Custom integrated circuits (ICs) designed specifically for low-noise neuromuscular signal acquisition directly through skin contact without surgical intervention.
Adaptive Neural AI Models
Cloud-hosted neural networks trained on proprietary biosignal datasets to isolate pathological tremor signatures from intentional physical movement.
Targeted Neuromodulation
Precision electrical pulses delivered to wrist nerve fibers, modifying disrupted spinal and cortical tremor loops to produce immediate functional stability.
Quality & Scalability
Medical-grade manufacturing compliance (ISO 13485) designed for high reliability, global distribution, and full traceability across clinical supply chains.
Clinical Excellence
Double-Blind Multi-Center Validation
Efficacy, patient safety, and regulatory compliance guide all engineering decisions at Fasikl. Felix NeuroAI™ Wristband, our flagship AI therapeutic device, underwent rigorous multi-stage clinical trials to demonstrate therapeutic safety and performance.
The landmark Stage 3 pivotal study was structured as a double-blind, randomized, sham-controlled clinical trial executed across more than 10 major US medical centers and hospital networks.
- Statistically Superior Performance: At the 90-day post-treatment mark, the active cohort achieved statistically significant hand tremor reduction over the sham group (p < 0.0001).
- Zero Surgical Risks: Delivered completely through a wristwatch-style form factor with no implants, brain leads, or systemic pharmaceutical side effects.
- High Compliance: Designed for effortless daily home usage under physician oversight, enabling sustained long-term patient adherence.
Global Supply & Medical Partnerships
Partnering with Overseas Healthcare Procurement & Distributors
Fasikl works directly with international medical device distributors, hospital procurement teams, movement disorder centers, and healthcare networks seeking FDA-cleared bioelectronic technologies.
Regulatory & Compliance Dossiers
Complete Technical Files, ISO 13485 quality documentation, FDA clearance records, and clinical study whitepapers available for regional regulatory submissions and registration.
Clinician Support & Training
Structured training modules, patient calibration protocols, and digital clinical dashboards to help hospital staff incorporate Neuro-AI therapeutics efficiently into daily neurology workflows.
Reliable Supply Chain Infrastructure
Robust manufacturing capabilities engineered to fulfill volume procurement orders for hospital systems, clinical trial sites, and regional healthcare tenders.
Continuous AI Calibration Platform
Cloud architecture providing seamless over-the-air algorithm refinements, ensuring devices deployed across global partner networks stay at peak clinical performance.